Literature DB >> 1081007

Trigger factors and HL-A antigens in chronic active hepatitis.

J Lindberg, A Lindholm, P Lundin, S Iwarson.   

Abstract

Forty-six patients with histologically verified chronic active hepatitis (CAH) were divided into three groups according to whether the CAH was virus-induced, drug-induced, or cryptogenic. The frequency of the HL-A antigens 1 and 8 was increased in the cryptogenic group while the other groups did not differ significantly from healthy controls. Autoantibodies were often found in high titres in the drug-induced and cryptogenic groups but were infrequent in the virus-induced group.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081007      PMCID: PMC1674938          DOI: 10.1136/bmj.4.5988.77

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  PHENYLBUTAZONE HEPATITIS.

Authors:  J A ECKER
Journal:  Am J Gastroenterol       Date:  1965-01       Impact factor: 10.864

2.  Acute submassive hepatic necrosis due to methyldopa. A case demonstrating possible initiation of chronic liver disease.

Authors:  I L Schweitzer; R L Peters
Journal:  Gastroenterology       Date:  1974-06       Impact factor: 22.682

3.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

4.  Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin.

Authors:  T B Reynolds; R L Peters; S Yamada
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

5.  Rapid diagnosis of influenza by immunofluorescent techniques.

Authors:  J McQuillin; P S Gardner; R McGuckin
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

6.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

7.  Isoniazid hepatitis.

Authors:  W C Maddrey; J K Boitnott
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

8.  Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics.

Authors:  S Iwarson; P Lundin; J Holmgren; S Hermodsson
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

9.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

10.  Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; K G Wakim; J W Worthington; L E Ward
Journal:  Medicine (Baltimore)       Date:  1967-01       Impact factor: 1.889

View more
  9 in total

Review 1.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

Review 3.  Immunological changes in liver disease.

Authors:  S Sherlock
Journal:  Proc R Soc Med       Date:  1977-12

4.  The natural history of histologically proved drug induced liver disease.

Authors:  P G Aithal; C P Day
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

5.  Interaction of HLA and Gm in autoimmune chronic active hepatitis.

Authors:  S Whittingham; J D Mathews; M S Schanfield; B D Tait; I R Mackay
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Chronic active hepatitis in patients with and without hepatitis B surface antigenemia.

Authors:  A Pár; K Barna; G Bajtai; M Balázs; A Patakfalvi; A Gógl
Journal:  Infection       Date:  1977       Impact factor: 3.553

7.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases.

Authors:  U Tage-Jensen; W Arnold; O Dietrichson; F Hardt; U Hopf; K H Meyer Zum Büschenfelde; J O Nielsen
Journal:  Br Med J       Date:  1977-01-22

8.  Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.

Authors:  M W Fried; J O Draguesku; M Shindo; L H Simpson; S M Banks; J H Hoofnagle; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

9.  Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Authors:  Jagannath M Sherigar; Richard Fazio; Minsheng Zuang; Edward Arsura
Journal:  Clin Pract       Date:  2012-10-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.